Clinical development of asciminib (ABL001) in chronic myeloid leukemia (CML): A randomized phase 3 study vs. bosutinib Meeting Abstract


Authors: Mauro, M. J.; Lang, F.; Kim, D. W.; Cortes, J. E.; Hughes, T. P.; Hochhaus, A.; Minami, H.; Boquimpani, C.; Minami, Y.; DeAngelo, D. J.; Breccia, M.; Talpaz, M.; Goh, Y. T.; Ottmann, O.; Sondhi, M.; Hois, S.; B├ędoucha, V.; Schmitz, S. F. H.; Rea, D.
Abstract Title: Clinical development of asciminib (ABL001) in chronic myeloid leukemia (CML): A randomized phase 3 study vs. bosutinib
Meeting Title: 54th Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 36
Issue: 15 Suppl.
Meeting Dates: 2018 Jun 1-5
Meeting Location: Chicago, IL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2018-05-20
Start Page: 398s
Language: English
ACCESSION: WOS:000442916007712
DOI: 10.1200/JCO.2018.36.15_suppl.TPS7081
PROVIDER: wos
Notes: Meeting Abstract: TPS7081 -- Source: Wos
Altmetric Score
MSK Authors
  1. Michael John Mauro
    114 Mauro